Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ho, Chen Hsun ^a,b   Yu, Hong Jeng ^b   Wang, Chih Yuan ^b   Jaw, Fu Shan ^c   Hsieh, Ju Ton ^b   Liao, Wan Chung ^b   Pu, Yeong Shiau ^b   Liu, Shih Ping ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK ASSESSMENT; RISK FACTOR; SEX HORMONE DETERMINATION; TESTOSTERONE BLOOD LEVEL;

BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; GONADAL STEROID HORMONES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; PREDIABETIC STATE; RISK FACTORS; TESTOSTERONE;

EID: 84884182849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074173     Document Type: Article

References (43)

1. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH, (2007) Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 30: 911-917. doi:10.2337/dc06-1426. PubMed: 17392552.
2. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, et al. (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89: 5462-5468. doi:10.1210/jc.2004-0804. PubMed: 15531498.
3. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, et al. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93: 1834-1840. doi:10.1210/jc.2007-2177. PubMed: 18319314.
4. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L, (1996) Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 143: 889-897.
5. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL, (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25: 55-60. doi:10.2337/diacare.25.1.55. PubMed: 11772901.
6. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB, (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23: 490-494. doi:10.2337/diacare.23.4.490. PubMed: 10857940.
7. Lakshman KM, Bhasin S, Araujo AB, (2010) Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci 65: 503-509. PubMed: 20106959.
8. Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, et al. (2011) Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 34: 1669-1675. doi:10.2337/dc10-2339. PubMed: 21709300.
9. Grossmann M, (2011) Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 96: 2341-2353. doi:10.1210/jc.2011-0118. PubMed: 21646372.
10. Association AD (2012) Diagnosis and classification of diabetes mellitus. Diabetes care 35 Suppl 1: S64-71.
11. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M, (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379: 2279-2290. doi:10.1016/S0140-6736(12)60283-9. PubMed: 22683128.
12. Yeap BB, Chubb SA, Hyde Z, Jamrozik K, Hankey GJ, et al. (2009) Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur J Endocrinol 161: 591-598. doi:10.1530/EJE-09-0348. PubMed: 19661128.
13. Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ, (2004) Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 27: 861-868. doi:10.2337/diacare.27.4.861. PubMed: 15047639.
14. Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint-Paul M, et al. (1992) Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 35: 173-177. doi:10.1007/BF00402551. PubMed: 1547923.
15. Vermeulen A, Verdonck L, Kaufman JM, (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672. doi:10.1210/jc.84.10.3666. PubMed: 10523012.
16. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, et al. (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92: 4241-4247. doi:10.1210/jc.2007-1245. PubMed: 17698901.
17. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, et al. (2004) Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89: 5920-5926. doi:10.1210/jc.2003-031719. PubMed: 15579737.
18. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C, (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Practice 60: 762-769. PubMed: 16846397.
19. Rosenstock J, Klaff LJ, Schwartz S, Northrup J, Holcombe JH, et al. (2010) Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. Diabetes Care 33: 1173-1175. doi:10.2337/dc09-1203. PubMed: 20332357.
20. Onat A, Can G, Ciçek G, Ayhan E, Doǧan Y, et al. (2011) Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults. Acta Diabetol: ([MedlinePgn:]) doi:10.1007/s00592-011-0313-x. PubMed: 21769500.
21. Abdul-Ghani MA, Tripathy D, DeFronzo RA, (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29: 1130-1139. doi:10.2337/dc05-2179. PubMed: 16644654.
22. Goodman-Gruen D, Barrett-Connor E, (2000) Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23: 912-918. doi:10.2337/diacare.23.7.912. PubMed: 10895840.
23. Corona G, Rastrelli G, Balercia G, Lotti F, Sforza A, et al. (2012) Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. J Sex Med 9: 1669-1680. doi:10.1111/j.1743-6109.2012.02717.x. PubMed: 22489756.
24. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221. doi:10.1016/S0140-6736(09)60619-X. PubMed: 19515410.
25. Bergman M, (2012) Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine, 43: 504-13. doi:10.1007/s12020-012-9830-9. PubMed: 23132321.
26. Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, et al. (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29: 1909-1914. doi:10.2337/dc06-0438. PubMed: 16873801.
27. Basu R, Barosa C, Jones J, Dube S, Carter R, et al. (2013) Pathogenesis of Prediabetes: Role of the Liver in Isolated Fasting Hyperglycemia and Combined Fasting and Postprandial Hyperglycemia. J Clin Endocrinol Metab, 98: E409-17. doi:10.1210/jc.2012-3056. PubMed: 23345093.
28. Saukkonen T, Cederberg H, Jokelainen J, Laakso M, Harkonen P, et al. (2011) Limited overlap between intermediate hyperglycemia as defined by A1C. pp. 5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes care 34: 2314-2316.
29. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, et al. (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91: 813-819. PubMed: 16352690.
30. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, et al. (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583. doi:10.1007/s001250050617. PubMed: 8960845.
31. Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, et al. (2011) Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 34: 2237-2243. doi:10.2337/dc10-2414. PubMed: 21949221.
32. Barr RG, Nathan DM, Meigs JB, Singer DE, (2002) Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137: 263-272. doi:10.7326/0003-4819-137-4-200208200-00011. PubMed: 12186517.
33. Avogaro A, (2011) Postprandial glucose: marker or risk factor? Diabetes Care 34: 2333-2335. doi:10.2337/dc11-1442. PubMed: 21949226.
34. Cichosz SL, Fleischer J, Hoeyem P, Laugesen E, Poulsen PL, et al. (2013) Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes. Diabetes Technol Ther 15: 78-83. doi:10.1089/dia.2012.0199. PubMed: 23176177.
35. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27: 1036-1041. doi:10.2337/diacare.27.5.1036. PubMed: 15111517.
36. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361: 1152-1163. doi:10.1056/NEJMoa0804381. PubMed: 19657112.
37. Kapoor D, Goodwin E, Channer KS, Jones TH, (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154: 899-906. doi:10.1530/eje.1.02166. PubMed: 16728551.
38. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, et al. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73: 602-612. doi:10.1111/j.1365-2265.2010.03845.x. PubMed: 20718771.
39. Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, et al. (2011) Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 34: 828-837. doi:10.2337/dc10-1233. PubMed: 21386088.
40. Heufelder AE, Saad F, Bunck MC, Gooren L, (2009) Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 30: 726-733. doi:10.2164/jandrol.108.007005. PubMed: 19578132.
41. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, et al. (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116: 151-157. doi:10.1161/CIRCULATIONAHA.106.685628. PubMed: 17576864.
42. Laughlin GA, Barrett-Connor E, Bergstrom J, (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93: 68-75. PubMed: 17911176.
43. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, et al. (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 2536-2559. doi:10.1210/jc.2009-2354. PubMed: 20525905.